
|Articles|July 11, 2012
Drug Cost Control in Oncology
Panel members are asked to discuss what drives the cost of drugs in cancer care. They also discuss the role companion diagnostics and personalized medicine play in oncology.
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
2
Hereditary Ovarian Cancer Genes Found Beyond Traditionally High-Risk Groups
3
Medicaid Expansion Associated With Lower Mortality in NSCLC
4
ACIP Delayed Hepatitis B Vaccine Schedule Vote Amid Safety Controversy
5













































